Cellframe is projected to rise to $0.0601 by 2027, a +78% move from its current price of $0.0338. CELL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 27/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $0.0319 | $0.0337 | $0.0356 | -0.19% |
| Aug 3 | $0.0311 | $0.0336 | $0.0364 | -0.38% |
| Aug 4 | $0.0305 | $0.0336 | $0.0369 | -0.58% |
| Aug 5 | $0.03 | $0.0335 | $0.0374 | -0.77% |
| Aug 6 | $0.0296 | $0.0334 | $0.0378 | -0.96% |
| Aug 7 | $0.0292 | $0.0334 | $0.0382 | -1.15% |
| Aug 8 | $0.0288 | $0.0333 | $0.0385 | -1.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0288 | $0.0333 | $0.0385 | -1.34% |
| Week 2 | $0.0268 | $0.0329 | $0.0404 | -2.66% |
| Week 3 | $0.0252 | $0.0324 | $0.0417 | -3.96% |
| Week 4 | $0.0239 | $0.032 | $0.0428 | -5.24% |
| Week 5 | $0.0228 | $0.0316 | $0.0437 | -6.51% |
| Week 6 | $0.0218 | $0.0311 | $0.0445 | -7.76% |
| Week 7 | $0.0209 | $0.0307 | $0.0451 | -8.99% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cellframe Network is a scalable, open-source, next-generation platform for building and bridging blockchains and services secured by post-quantum encryption. Cellframe offers an environment for enterprises and developers to build a vast array of products ranging from simple low-level t-dApps to whole other blockchains on top of Cellframe Network. Cellframe can provide extremely high transaction throughput based on an original sharding implementation.
In addition, post-quantum cryptography makes the system resistant to hacking by quantum computers. Cellframe Network is built with a unique implementation of dual-layer sharding, conditional transactions and multiparty computations. This allows seamless interoperability, as well as fast and economical transactions, all secured by integrated quantum safety measures.
Since the platform is built from scratch using plain C, t-dApps built on our SDK can be executed on anything from enterprise-level mainframes to a smart fridge, which enables developers to build a wide range of applications.
Cellframe (CELL) is currently trading at $0.0338, with a market cap of $1.25M and a market rank of 2627. Its all-time high is $7.21 and its all-time low is $0.0297, highlighting significant volatility. The near-term technical picture is bearish, while the longer-term forecast shows a path of potential gains across multiple years.
A major floor 45.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.1% away) — a key level to hold.
The nearest ceiling, 63.6% above — a clean break opens room to run.
A major ceiling 86.3% above — clearing it would confirm fresh momentum.
Key CELL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CELL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0335 | Buy | $0.034 | Sell |
| MA 10 | $0.0352 | Sell | $0.0351 | Sell |
| MA 20 | $0.0375 | Sell | $0.0368 | Sell |
| MA 50 | $0.0376 | Sell | $0.0388 | Sell |
| MA 100 | $0.0411 | Sell | $0.0441 | Sell |
| MA 200 | $0.0561 | Sell | $0.0668 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.56 | Neutral |
| Stoch RSI (14) | 22.60 | Neutral |
| CCI (20) | -84.09 | Neutral |
| Williams %R (14) | -87.43 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -13.98 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 12.57 | Buy |
| TRIX (15) | -0.41 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 31.61 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 0.03 | Buy |
| ADX (14) | 17.04 | Neutral |
| ATR (14) | 0.00 | Info |
The 30-day picture shows bearish sentiment, with RSI(14) at 40 and price action below the key longer-term average levels. The SMA50 stands at $0.0376 and the SMA200 sits at $0.0721, indicating the longer-term trend remains higher than the near-term price. Support is identified at $0.033 and resistance at $0.0553, with a 30-day price range from $0.025 to $0.0456.
The volatility backdrop is high, as reflected by an annualized volatility of 100%. These dynamics suggest limited near-term upside unless support holds or momentum shifts toward the indicated resistance level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0309 | $0.0338 | $0.0503 | 0% | Neutral | |
| $0.0438 | $0.0601 | $0.0893 | +78% | Bullish | |
| $0.0426 | $0.0623 | $0.0987 | +84% | Bullish | |
| $0.0308 | $0.0475 | $0.0791 | +41% | Bullish | |
| $0.0265 | $0.0428 | $0.0742 | +27% | Bullish | |
| $0.0413 | $0.0697 | $0.1251 | +106% | Bullish | |
| $0.0412 | $0.0725 | $0.1343 | +115% | Bullish | |
| $0.0358 | $0.0657 | $0.125 | +95% | Bullish | |
| $0.0219 | $0.0418 | $0.0815 | +24% | Bullish | |
| $0.0414 | $0.0822 | $0.1641 | +143% | Bullish | |
| $0.0461 | $0.1025 | $0.225 | +203% | Bullish | |
| $0.035 | $0.0779 | $0.1791 | +131% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.0309 | $0.0338 | $0.0491 | +0.00% |
| September 2026 | $0.0267 | $0.0325 | $0.0413 | -3.82% |
| October 2026 | $0.023 | $0.0283 | $0.0367 | -12.75% |
| November 2026 | $0.0287 | $0.0358 | $0.0472 | +26.35% |
| December 2026 | $0.0298 | $0.0376 | $0.0503 | +5.06% |
Click any year to see its month-by-month CELL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CELL price prediction for 2026 points to an average of $0.0338 (low $0.0309, high $0.0503) — a potential gain of 0% on today's $0.0338. A consolidation phase looks the most probable path here.
In 2027, CELL is projected to trade between $0.0438 and $0.0893, averaging $0.0601 — a potential gain of +78% from today's $0.0338. That is up +78% on the projected 2026 average. Momentum favours further upside here.
Cellframe's 2028 outlook centres on $0.0623, within a $0.0426 to $0.0987 range. That is up +4% on the projected 2027 average. That marks a +84% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, CELL could reach as high as $0.0791, with a base case around $0.0475 and support toward $0.0308 — roughly +41% from $0.0338. Momentum favours further upside here.
Expect CELL to range from $0.0265 to $0.0742 through 2030. The $0.0428 average target implies a +27% move from current prices. That is -10% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The CELL price prediction for 2031 points to an average of $0.0697 (low $0.0413, high $0.1251) — a potential gain of +106% on today's $0.0338. Momentum favours further upside here.
In 2032, CELL is projected to trade between $0.0412 and $0.1343, averaging $0.0725 — a potential gain of +115% from today's $0.0338. That is up +4% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Cellframe's 2033 outlook centres on $0.0657, within a $0.0358 to $0.125 range. That is -9% versus the projected 2032 average. That marks a +95% change versus current levels. Momentum favours further upside here.
By 2034, CELL could reach as high as $0.0815, with a base case around $0.0418 and support toward $0.0219 — roughly +24% from $0.0338. Buyers look set to stay in control over this stretch.
Expect CELL to range from $0.0414 to $0.1641 through 2035. The $0.0822 average target implies a +143% move from current prices. That is up +97% on the projected 2034 average. Momentum favours further upside here.
The CELL price prediction for 2040 points to an average of $0.1025 (low $0.0461, high $0.225) — a potential gain of +203% on today's $0.0338. Buyers look set to stay in control over this stretch.
In 2050, CELL is projected to trade between $0.035 and $0.1791, averaging $0.0779 — a potential gain of +131% from today's $0.0338. That is -24% versus the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CELL today (≈ 29,613.932052 CELL) could be worth
$2,306.58
+$1,306.58 (+131%) by 2050 · US Dollar
Based on the average projected CELL price of $0.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CELLwould be worth at today's price.
$1,000 invested in CELL on Aug 1, 2025 (≈ 3,018.283955 CELL) would be worth
$101.92
-$898.08 (-89.8%) today · 0.10× · US Dollar
Based on a CELL entry price of $0.331314 vs. today's $0.033768.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.036944 | $914.03 | -8.6% |
| 1 month ago | $0.037128 | $909.51 | -9.0% |
| 3 months ago | $0.046408 | $727.62 | -27.2% |
| 6 months ago | $0.078427 | $430.57 | -56.9% |
| 1 year ago | $0.331314 | $101.92 | -89.8% |
| All time (1.2y) ago | $0.335366 | $100.69 | -89.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CELL forecast.
Our base-case forecast reaches $0.068 around 2031.
Implied market cap at $0.068: $2.53M
The multi-year forecast paints a bullish arc after 2026, with a sequence of rising average prices and meaningful ROIs in several years. In 2030 the average price is projected at $0.0428 with a 26.8% ROI, following a path that starts modestly in 2026 at $0.0338. By 2040, the average is forecast at $0.1025 with a 203.4% ROI, and by 2050 the average stands at $0.0779 with a 130.7% ROI.
This trajectory comes amid bullish sentiment in later years, supported by a broad upward revision of average price across multiple years and notable upside potential in the longer term.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.0428 with a ROI of 26.8% (min $0.0265, max $0.0742).
The forecast contains bullish sentiment in many years from 2027 onward, with several years showing positive ROI values. These are estimates and not guarantees.
Yes. The 2040 forecast lists an average price of $0.1025 with a ROI of 203.4%, which implies potential to reach or exceed $0.10 in that horizon.
Current price is $0.0338 and market cap is $1.25M.
All-time high is $7.21 and all-time low is $0.0297.
Cellframe Community Discussion
0Share your Cellframe price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.